Abiopharma

Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic

NETSCOUT Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results

Gibraltar Reports First Quarter 2026 Results

Cardiol Therapeutics Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

MarketWise Reports Net Revenue of $77.0 Million and Net Loss of $0.6 Million for First Quarter 2026; Q1 Billings Increase 15% YoY; Announced Quarterly Regular and Special Dividends totaling $0.45 per Class A share; Affirms FY 2026 Guidance of Billings of $300 Million and CFFO of $50 Million; Board Authorizes …

CPRX Stock Alert: Halper Sadeh LLC is Investigating Whether Catalyst Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

USANAs People-First Culture Earns Spot on USA TODAY Top Workplaces List

Americold Realty Trust, Inc. and EQT Announce a $1.3 Billion North American Cold Storage Joint Venture USA - English USA - English

enGene Announces Updated Interim Results From LEGEND Pivotal Cohort

Nuveen Churchill Direct Lending Corp. Announces First Quarter 2026 Results